Published papers from second round of cohort of:

“(Kerman Coronary Artery Disease Risk Factors Study (KERCADRS”

1. Shadkam Farokhi M., Safi Z., Sanjari M., Shadman H., Kahnouji M., Najafipour H., Zeinali Nezhad N. Prevalence of Poor Glycemic Control and Its Related Factors Among Iranian Diabetic Patients Who Participated in KERCARDS. Int Arch Health Sci, 2025;12(3):150-156. doi: 10.48307/iahsj.2025.440930.1138

2. Najmeh Davoodian, Mojtaba Lotfaliany, Rachel R Huxley, Crystal Man Ying Lee, Julie A Pasco, Robert J Adams, Fereidoun Azizi, Alain G Bertoni, Cecilia Björkelund, Stephen Colagiuri, Noushin Fahimfar, Rafael Gabriel, Vilmantas Giedraitis, Tiffany K Gill, Clicerio González, Edward W Gregg, Farzad Hadaegh, Dominique Hange, Jacob W Harland, Allison M Hodge, Kara L Holloway-Kew, Seyed Reza Hosseini, David R Jacobs, Davood Khalili, Dianna J Magliano, Morgana Mongraw-Chaffin, Gita D Mishra, Lauren Lissner, Kirsten Mehlig, Hamid Najafipour, Ramfis Nieto-Martinez, Afshin Ostovar, Mitra Shadkam, Jonathan E Shaw, Valter Sundh, Pamela J Schreiner, Masaru Sakurai, Gary A Wittert, Hiroshi Yatsuya, Bjorn Zethelius, Mohammadreza Mohebbi,Prediabetes transitions to normoglycaemia or type 2 diabetes and associated risk factors in the Obesity, Diabetes and Cardiovascular Disease Collaboration: an individual-level pooled analysis of 19 prospective cohort studies,The Lancet Global Health,Volume 13, Issue 9,2025,Pages e1533-e1542.

3.Mokhtari Ardekani A, Mousavi Mehdiabadi F, Jabbari Moroei M. Comparison of Inflammatory Markers and White Blood Cell Levels between Diabetic Patients and Healthy Subjects. Journal of Babol University of Medical Sciences. 2024; 26: e70.10.22088/jbums.26.1.70

4.Yousefzadeh G, Sayyadi A, Najafipour H, Sabaghnejad V, Pezeshki S. Comparing the association of two metabolic syndrome definitions, NCEP ATP III and IDF, with the risk of developing atherosclerotic cardiovascular disease: An analytical cross-sectional study. Endocrinol Diab Metab. 2024;7:e468. doi:10.1002/edm2.468.

5.Salarpour E, Najafipour H, Mirzaee M. Evaluation of the effect of demographic, biochemical, and lifestyle variables on incidence of hypertension in the last five years in Kerman: findings from KERCADRS cohort study. Journal of Kerman University of Medical Sciences. 2024;31(5):266–271.https://doi.org/10.34172/jkmu.2024.41

6.Baniasad A, Najafzadeh MJ, Najafipour H, Gozashti MH. The prevalence of metabolically healthy obesity and its transition into the unhealthy state: A 5-year follow-up study. Clinical Obesity. 2024;e12691.doi: 10.1111/cob.12691.

7.Zeinali-Nezhad N, Najafipour H, Shadkam M, Pourhamidi R. Prevalence and trend of multiple coronary artery disease risk factors and their 5-year incidence rate among adult population of Kerman: results from KERCADR study. BMC Public Health. 2024 Jan 2;24(1):25.doi: 10.1186/s12889-023-17504-8.

8.Tajadini H, Bazrafshani MS, Kamali M. The Warm Temperament (Mizaj) as a Predictor of Anxiety Disorder among Participants in the Kerman Coronary Artery Disease Risk Factors Study (KERCADRS). Trad Integr Med 2023;8(2):137-143.doi.org/10.18502/tim.v8i2.13079

9. Enhesari A, Abasnia R, Baniasad A, Narouee Nosrati S, Najafipour H, Najafzadeh MJ, et al. Investigating the relationship between carotid intima-media thickness (cimt), opium addiction, and components of the metabolic syndrome. Addict Health. 2023;15(2):93–99.doi:10.34172/AHJ.2023.1388

10. Yeganeh-Hajahmadi M, Mehrabani M, Esmaili M, Farokhi MS, Sanjari M. Protamine as a barrier against the angiogenic effect of insulin: a possible role of apelin. Sci Rep. 2023 Oct 12;13(1):17267.doi: 10.1038/s41598-023-44639-w.

11. Jafari, A., Najafipour, H., Shadkam, M. et al. Evaluation of the novel three lipid indices for predicting five- and ten-year incidence of cardiovascular disease: findings from Kerman coronary artery disease risk factors study (KERCADRS). Lipids Health Dis 22, 169 (2023).doi: 10.1186/s12944-023-01932-x.

12. Najafzadeh MJ, Baniasad A, Shahabinejad R, Mashrooteh M, Najafipour H, Gozashti MH.Investigating the relationship between haematological parameters and metabolic syndrome: A population-based study. Endocrinol Diab Metab. 2023.doi: 10.1002/edm2.407.

13. Mahmoodzadeh S, Jahani Y, Najafipour H, Sanjari M, Shadkam-Farokhi M, et al. External Validation of Finnish Diabetes Risk Score and Australian Diabetes Risk Assessment Tool Prediction Models to Identify People with Undiagnosed Type 2 Diabetes: A Cross-sectional Study in Iran. Int J Endocrinol Metab. 2022;20(4):e127114.doi: 10.5812/ijem-127114.

14. Zamaninasab Z, Najafipour H, Mirzaee M, Bahrampour A. A Cluster-wise Linear Regression Model to Investigate the Effect of Demographical and Clinical Variables on the Average Depression Score. Med J Islam Repub Iran. 2022 (8 Oct);36:116.doi: 10.47176/mjiri.36.116.

15.Yazdi F, Baghaei MH, Baniasad A, Naghibzadeh-Tahami A, Najafipour H, Gozashti MH. Investigating the relationship between serum uric acid to high-density lipoprotein ratio and metabolic syndrome.Endocrinol Diab Metab. 2022;5:e00311.doi: 10.1002/edm2.311.

16. Alemeh Peydayesh, Hamid Najafipour, Zohreh Rahaei, Mitra Shadkam-Farokhi, & Sara Jambarsang. (2022). Risk Factors of Myocardial Infarction in the Elderly People: Results of Kerman Coronary Artery Disease Risk Factors Cohort Study (KERCADRS). Journal of Pharmaceutical Negative Results, 1562–1568.doi.org/10.47750/pnr.2022.13.S03.240

17. Amini F, Khajevand Khoshli A, Asadi J, Bahar A, Najafipour H, Mirzazadeh A. Obesity Mediates the Effect of Past and Current Mental Health on Diabetes Treatment Outcomes. Iran J Public Health. 2022;51(11):2608-2618.doi: 10.18502/ijph.v51i11.11180.

 18. Najafipour H, Mahdavi A , Kordestani Z, Zamaninasab Z, Shadkam Farokhi M, Shamsadini A, Azizi E. The prevalence and 5-year incidence rate of cigarette smoking and water-pipe tobacco smoking and their associated factors among 15 to 80 years old urban population in southeast Iran: results from KERCADR study. Addict Health. 2022;14(3):205-213. doi: 10.34172/ahj.2022.1273.

19. Yazdi F, Shakibi MR, Baniasad A, et al. Hyperuricaemia and its association with other risk factors for cardiovascular diseases: A population-based study. Endocrinol Diab Metab. 2022;00:e387. doi: 10.1002/edm2.387.

20. Najafipour H, Sabahi A, khoramipour kayvan, Shojaei Shahrokhabad M, Banivaheb G, Shadkam M, Mirzazadeh A. Prevalence, Incidence and Health Impacts of Sleep Disorders on Coronary Artery Disease Risk Factors: Results of a Community-Based Cohort Study (KERCADRS). Iran J Psychiatry. 2022;17(3):247-256.doi: 10.18502/ijps.v17i3.9723.

21. Mahmoodi MR, Najafipour H (2022) Association of C-peptide and lipoprotein(a) as two predictors with cardiometabolic biomarkers in patients with type 2 diabetes in KERCADR population-based study. PLoS ONE 17(5): e0268927.doi: 10.1371/journal.pone.0268927. 

22. Mahmoodi MR, Najafipour H. Associations between serum vitamin D3, atherogenic indices of plasma and cardiometabolic biomarkers among patients with diabetes in the KERCADR study. BMC Endocr Disord. 2022 May 12;22(1):126.doi: 10.1186/s12902-022-01043-1.

23. Jangipour Afshar P, Najafipour H, Shadkam Farokhi M, Shahesmaeili A. How Much Excess Body Weight, Blood Pressure, Triglyceride, or Age Can Double the Likelihood of Diabetes Type 2?. Iran J Public Health. 2022;51(4):939-945.doi: 10.18502/ijph.v51i4.9256

24. Najafipour H, Masoumi M, Amirzadeh R, Rostamzadeh F, Foad R, Shadkam Farrokhi M. Trends in the Prevalence and Incidence of Opium Abuse and its Association with Coronary Artery Risk Factors in Adult Population in Iran: Findings from Kerman Coronary Artery Disease Risk Factors Study. Iran J Med Sci.doi: 10.30476/IJMS.2021.89898.2065.

25. Najafipour H, Farjami M, Sanjari M, Amirzadeh R, Shadkam Farokhi M and Mirzazadeh A (2021) Prevalence and Incidence Rate of Diabetes, Pre-diabetes, Uncontrolled Diabetes, and Their Predictors in the Adult Population in Southeastern Iran: Findings From KERCADR Study. Front. Public Health 9:611652.doi: 10.3389/fpubh.2021.611652.

26. Najafipour H, Abdollahi F, Khatibi M, Amirzadeh R. Dietary status with demographic and anthropometric variables and some health affecting risk factors in people of Southeastern Iran: A population-based study (KERCADRS). Caspian J Intern Med 2021; 12(4): 551-561.doi: 10.22088/cjim.12.4.551.

27. Yazdi F, Baghaei MH, Baniasad A, Naghibzadeh-Tahami A, Najafipour H, Gozashti MH. Investigating the relationship between serum uric acid to high-density lipoprotein ratio and metabolic syndrome. Endocrinol Diab Metab. 2021;00:e311.doi: 10.1002/edm2.311. 

28. Yeganeh-Hajahmadi, M., Najafipour, H., Rostamzadeh, F. et al. Klotho and SIRT1 changes from pre-diabetes to diabetes and pre-hypertension to hypertension. Diabetol Metab Syndr 13, 115 (2021).doi: 10.1186/s13098-021-00736-2.

29. Najafipour H, Yousefzadeh G, Baneshi MR, Ahmadi Gohari M, Shahouzehi B, Farokhi MS, et al. Prevalence and 5‑year incidence rate of dyslipidemia and its association with other coronary artery disease risk factors in Iran: Results of the Kerman coronary artery disease risk factors study (Phase 2). J Res Med Sci 2021;26:99.doi: 10.4103/jrms.JRMS_748_20.

30. Najafipour H; Bagheri M; Saberi S; Farokhi M; Amirzadeh R; Mirzazadeh A. Epidemiological update on prevalence and incidence of overweight and obesity in adults in the south-east of the Islamic Republic of Iran: findings from the Kerman Coronary Artery Diseases Risk FActors Study (KERCADRS). East Mediterr Health J. 2021;27(9):874-883.doi: 10.26719/emhj.21.035.

31. Enhesari A, Khatami M, Gozashti M H, Safi Z, Khatami M. A study on the relationship between serum uric acid and the thickness of intima-mediated carotid. J Adv Pharm Educ Res. 2021;11(3):83-7.https://doi.org/10.51847/TfjLbFn5kr.

32. Najafipour H, Sadeghi M, Kordestani Z, Naghibzadeh Tahamy A, Ghavipisheh M, Shadkam Farokhi M. The Prevalence of Musculoskeletal Pain Syndrome in 15-80 years old Population of Kerman: The Role of Smart Phone Use and its Related Factors. Journal of Kerman University of Medical Sciences 2021; 28(4): 358-366.doi.org/10.22062/jkmu.2021.91716

33. Nekouei AH, Kakooei S, Najafipour H, Kakoei S. Oral Health Determinants among Opium Users in Kerman, Iran. Addict Health 2021; 13(3):156-164.doi: 10.22122/ahj.v13i3.307.

34. Najafipour H, Shahrokhabadi MS, Banivaheb G, et al. Trends in the prevalence and incidence of anxiety and depressive symptoms in Iran: findings from KERCADRS. Fam Med Com Health 2021;9:e000937.doi: 10.1136/fmch-2021-000937.

35. Kakoei Sh, Nekouei AH, Kakooei S, Najafipour H. The effect of demographic characteristics on the relationship between smoking and dry mouth in Iran:  a cross-sectional, case-control study. Epidemiol Health 2021:1-6.doi: 10.4178/epih.e2021017.

36. Daneshpajooh A, Naghibzadeh‐Tahami A, Najafipour H, Mirzaei M. Prevalence and risk factors of urinary incontinence among Iranian women. Neurourology and Urodynamics. 2021;1–11.doi: 10.1002/nau.24597.

37.Tavakolinejad Kermani, M., Sanjari, M., Nakhaei, N., Parirokh, M., & Abbott, P. (2020). Comparison of pulp sensibility tests responses in type 2 diabetes patients and healthy individuals

.Journal of Endodontics, 46(3), 364–369. doi: 10.1016/j.joen.2019.11.016.

38. Najafipour, H., Nasri, H.R., Rostamzadeh, F. et al. Prevalence and incidence of pre-hypertension and hypertension (awareness/control) in Iran: findings from Kerman coronary artery diseases risk factors study 2 (KERCADRS). J Hum Hypertens 2020.doi: 10.1038/s41371-020-00392-5.

39. Najafipour H, Kahnooji M,  Baneshi MR, Yeganeh M, Ahmadi Gohari M, Shadkam Farokhi M, Mirzazadeh A.The Prevalence and 5-Year Incidence Rate of Low Physical Activity in 10,000 Urban Population in South East of Iran: Relationship With Other Cardiovascular Risk Factors. Journal of Physical Activity and Health 2020;17(4):435-442.doi: 10.1038/s41371-020-0039.

40. Asadikaram G, Ram M,Izadi A, et al. The study of the serum level of IL‐4,TGF‐β, IFN‐γ, and IL‐6 in overweight patients with and without diabetes mellitus and hypertension.J Cell Biochem. 2018;1‐11.doi: 10.1002/jcb.27700.

41. Asadikaram G, Akbari H, Safi Z, Shadkam M, Khaksari M, Shahrokhi N, Najafipour H, Sanjari M, Arababadi MK. Downregulation of IL-22 can be considered as a risk factor for onset of type 2 diabetes. J Cell Biochem 2018 Jun;119(11).doi: 10.1002/jcb.27194.

42. Najafipour H, Sadeghigoghari M, Kordestani Z, Naghibzadeh Tahami A, Ghavipisheh M. et al. Prevalence of the Musculoskeletal Pain Syndrome and Its Associated Factors in People Between 15 and 80 Years in Kerman: A Population-based Study on 1700 Individuals, Iran Red Crescent Med J 2017;19(4):e45084.doi: 10.5812/ircmj.45084.